BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2021 4:26:46 AM | Browse: 497 | Download: 1187
 |
Received |
|
2020-12-19 16:26 |
|
Peer-Review Started |
|
2020-12-19 16:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-01-10 16:08 |
|
Revised |
|
2021-01-16 14:15 |
|
Second Decision |
|
2021-03-18 07:02 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-03-18 23:24 |
|
Articles in Press |
|
2021-03-18 23:24 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-03-25 01:14 |
|
Publish the Manuscript Online |
|
2021-04-15 04:26 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ioannis Ilias, Spyridon Goulas and Lina Zabuliene |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ioannis Ilias, MD, PhD, Consultant Physician-Scientist, Department of Endocrinology, Elena Venizelou Hospital, 2 Elena Venizelou Sq, Athens GR-11521, Greece. iiliasmd@yahoo.com |
| Key Words |
Adipose tissue; Obesity; Polycystic ovaries; SARS-CoV-2; COVID-19; Human |
| Core Tip |
Polycystic ovary syndrome (PCOS) may entail higher susceptibility to coronavirus disease 2019 (COVID-19). Furthermore, PCOS may also increase susceptibility to COVID-19 via its associated comorbidities (non-alcoholic fatty liver disease, metabolic syndrome and alterations in the gut microbiome). In order to determine whether the intestinal microbiome in women with PCOS has an effect on their risk of COVID-19 or if severe acute respiratory syndrome coronavirus 2 is the factor that changes the composition of their microbiome, more research will be needed. Strategies for adapting the intestinal microbiome could help reduce the severity of COVID-19 in women with PCOS. |
| Publish Date |
2021-04-15 04:26 |
| Citation |
Ilias I, Goulas S, Zabuliene L. Polycystic ovary syndrome: Pathways and mechanisms for possible increased susceptibility to COVID-19. World J Clin Cases 2021; 9(12): 2711-2720 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i12/2711.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i12.2711 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
